09 May 2017

GSK Stockmann contributed to the World Bank Group Report “Doing Business 2017”

The report Doing Business 2017 has just been published by the World Bank Group. It is one of its four flagship publications that benchmarks business regulations in 190 economies worldwide – from Afghanistan to Zimbabwe – and over time. Governments worldwide read the report with interest every year, and improve the strength of legal rights

GSK Stockmann also contributed to the report’s publication.
Andreas Heinzmann (lawyer and partner at our GSK Stockmann office in Luxembourg) and Valerio Scollo (lawyer and senior associate at our GSK Stockmann office in Luxembourg) contributed their expertise in the area of Getting Credit Legal Rights in Luxembourg. The Getting Credit Legal Rights indicator, which measures rights of secured creditors and borrowers in secured transactions, is one of the 11 indicator sets published by the Doing Business report. Moreover Jennifer Bierly (lawyer and partner at our GSK Stockmann office in Berlin) has participated in the Doing Business Report of the World Bank Group since its first publication in 2002. She contributes her expertise regarding the incorporation of enterprises in Germany.

The Guide is now free to access on the following website:
http://www.doingbusiness.org/reports/global-reports/doing-business-2017

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Andreas Heinzmann, LL.M. eur.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M. (NYU), LL.M. (NUS)

Partner

+352 271802-32

valerio.scollo@gsk-lux.com

© GSK Stockmann 2024